-65.7%
MRNA vs ETR
+122.3%
-188.0%
-95.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | ETR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -0.4% | +5.8% | +5.4% |
| 7D | -1.1% | -1.8% | +0.7% | -0.9% |
| 30D | +126.1% | -1.8% | +127.9% | +126.6% |
| 3M | +190.0% | -3.6% | +193.6% | +191.2% |
| 6M | +157.2% | +2.6% | +154.6% | +154.8% |
| YTD | +388.2% | +16.0% | +372.2% | +373.3% |
| 1Y | +467.0% | +20.1% | +446.9% | +447.9% |
| 3Y | +36.1% | +143.6% | -107.5% | +13.2% |
| All | -65.7% | +122.3% | -188.0% | -70.6% |
Cumulative growth
Daily Returns
Daily percentage return beside ETR.
Daily Out/Under-Performance
Portfolio return minus ETR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ETR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded ETR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling